Loading...
XSHE
300636
Market cap403mUSD
Jul 10, Last price  
6.67CNY
1D
2.30%
1Q
-18.06%
IPO
11.75%
Name

Jiangxi Synergy Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300636 chart
P/E
38.32
P/S
3.39
EPS
0.17
Div Yield, %
0.61%
Shrs. gr., 5y
4.46%
Rev. gr., 5y
6.91%
Revenues
827m
+8.96%
104,615,908141,555,600212,574,223274,814,061250,078,504296,716,026267,124,045413,058,080435,420,101592,126,648719,908,426719,908,426722,138,705758,890,498826,856,172
Net income
73m
-31.42%
8,028,34916,883,60739,208,36862,879,09857,996,31965,457,73024,530,82148,309,31170,051,15381,119,813100,667,359100,667,367105,983,261106,584,10473,091,433
CFO
202m
-29.02%
014,417,07264,501,99079,422,48260,445,42134,053,90474,932,539080,066,182131,338,816195,996,737163,748,533285,189,694202,438,392
Dividend
Jun 27, 20250.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in Yichun, People's Republic of China, Jiangxi Synergy Pharmaceutical Co., Ltd. was established in 2004. The company specializes in the global production and sale of active pharmaceutical ingredients (APIs), as well as liquid crystal compounds and various chemical intermediates.
IPO date
Mar 31, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT